Addex Therapeutics Ltd. (ADXN) stock
ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.50−0.33 (-8.62%)
Close on Nov 17, 2026Market cap $71.86KP/E –Yield –
Addex Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Addex Therapeutics's total assets was CHF 3.48M at Jun 30, 2026. For fiscal 2025 it was CHF 6.36M, down 40.4% from the year before. The highest annual figure on record is CHF 42.21M in fiscal 2018.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | CHF 6.36M | -40.4% |
| FY2024 | Dec 31, 2024 | CHF 10.68M | +130.0% |
| FY2023 | Dec 31, 2023 | CHF 4.64M | -44.0% |
| FY2022 | Dec 31, 2022 | CHF 8.28M | -63.3% |
| FY2021 | Dec 31, 2021 | CHF 22.54M | +11.7% |
| FY2020 | Dec 31, 2020 | CHF 20.18M | -38.9% |
| FY2019 | Dec 31, 2019 | CHF 33.03M | -21.8% |
| FY2018 | Dec 31, 2018 | CHF 42.21M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | CHF 3.48M | -25.0% |
| Q4 FY2025 | Dec 31, 2025 | CHF 6.36M | -29.3% |
| Q2 FY2025 | Jun 30, 2025 | CHF 8.51M | +2.7% |
| Q4 FY2024 | Dec 31, 2024 | CHF 10.68M | -6.2% |
| Q4 FY2023 | Dec 31, 2023 | CHF 4.64M | -79.4% |
| Q2 FY2023 | Jun 30, 2023 | CHF 9.00M | -55.4% |
| Q4 FY2022 | Dec 31, 2022 | CHF 8.28M | -74.9% |
| Q2 FY2022 | Jun 30, 2022 | CHF 11.38M | -73.0% |
| Q4 FY2021 | Dec 31, 2021 | CHF 22.54M | – |
| Q4 FY2020 | Dec 31, 2020 | CHF 20.18M | – |
| Q4 FY2019 | Dec 31, 2019 | CHF 33.03M | – |
| Q4 FY2018 | Dec 31, 2018 | CHF 42.21M | – |
See a number that looks wrong?